Livzon Pharmaceutical Group (000513.SZ) released its performance for the first three quarters, with net profit attributable to shareholders of RMB 1.288 billion, a year-on-year decrease of 26.57%.

Zhitong Finance APP News, Livzon Pharmaceutical Group (000513.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 7.319 billion yuan, a year-on-year decrease of 19.71%; net profit attributable to shareholders of the listed company was 1.288 billion yuan, a year-on-year decrease of 26.57%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 1.26 billion yuan, a year-on-year decrease of 26.38%; basic earnings per share were 1.45 yuan.